Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


National Institutes of Health (NIH) 

9000 Rockville Pike

Bethesda  Maryland  20892  U.S.A.
Phone: 301-496-4000 Fax:

Begun as a one-room Laboratory of Hygiene in 1887, the National Institutes of Health today is one of the world's foremost biomedical research centers, and the Federal focal point for biomedical research in the U.S.


The NIH mission is to uncover new knowledge that will lead to better health for everyone. NIH works toward that mission by: conducting research in its own laboratories; supporting the research of non-Federal scientists in universities, medical schools, hospitals, and research institutions throughout the country and abroad; helping in the training of research investigators; and fostering communication of medical information.

NIH is one of the agencies of the Public Health Services which, in turn, is part of the U.S. Department of Health and Human Services Comprised of 27 separate components, mainly Institutes and Centers, NIH has in excess of 75 buildings on more than 300 acres in Bethesda, Maryland. From a total of about $300 in 1887, NIH has been appropriated nearly $23.4 billion for 2002.


Simply described, the goal of NIH research is to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability, from the rarest genetic disorder to the common cold.

Last Updated: 07-08-03

 Key Statistics

Ownership: unknown

Web Site: NIH


 Company News
Varmus Stepping Down As Director Of NIH’s National Cancer Institute 3/5/2015 6:35:00 AM
Nascent Biotech Announces $225,000 NIH Grant Award In Conjunction With Mapp Biopharmaceutical 2/26/2015 10:46:39 AM
Recursion Pharmaceuticals Wins $1.5 Million NIH Grant For Rare Disease Drug Discovery 2/25/2015 10:45:40 AM
N2 Biomedical LLC Receives NIH Grant To Develop Antimicrobial Biodegradable Bone Graft For Craniofacial Applications 2/24/2015 11:11:14 AM
Stealth Biotherapeutics Presents At NIH Acute Kidney Injury Outcomes Meeting: Bendavia Clinical Results Highlighted During Industry Panel 2/23/2015 11:14:24 AM
Pressure BioSciences, Inc. (BBII) Awarded $1,000,000 NIH SBIR Phase 2 Grant 2/19/2015 9:14:06 AM
Regeneron (REGN) Release: NIH-Sponsored Comparative Effectiveness Trial In Diabetic Macular Edema Shows EYLEA (Aflibercept) Injection Demonstrated Significantly Greater Gains In Visual Acuity Than Both Bevacizumab And Ranibizumab 2/19/2015 6:12:29 AM
Significant Findings In NIH's Trial Of Pluristem Therapeutics (PSTI)'s PLX-R18 Cells For Treatment Of Acute Radiation Syndrome 2/18/2015 7:43:40 AM
VistaGen Therapeutics, Inc. And NIH Sign Agreement For NIH-Sponsored Phase 2 Study Of Orally-Active AV-101 In Major Depressive Disorder 2/17/2015 8:07:36 AM
Rheonix, Inc. Receives $1.5 Million SBIR Phase 2 Grant From NIH To Complete Development Of A Rapid Point-Of-Care Test For HIV/AIDS 2/10/2015 12:15:29 PM